News Headlines Article

Generic-drug approval growth doesn’t spark competition
Modern Healthcare

While more generic drugs are being approved, they are often versions that only marginally reduce prices, a new study found.

About 2,700 new generic drugs were approved from 2012 to 2017, up nearly 17% from 2008 to 2012, according to a new research brief from Pew Charitable Trusts. But most of those drugs are later iterations, not the second or third generics to market that most significantly lower prices. Nearly 550 off-patent brand drugs still lack competition, according to the Food and Drug Administration.